Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's Disease - Baakman_2021_Br.J.Clin.Pharmacol__ |
| Author(s) : Baakman AC , Gavan C , van Doeselaar L , de Kam M , Broekhuizen K , Bajenaru O , Camps L , Swart EL , Kalisvaart K , Schoonenboom N , Lemstra E , Scheltens P , Cohen A , van Gerven J , Groeneveld GJ |
| Ref : British Journal of Clinical Pharmacology , : , 2021 |
| Abstract : Baakman_2021_Br.J.Clin.Pharmacol__ |
| ESTHER : Baakman_2021_Br.J.Clin.Pharmacol__ |
| PubMedSearch : Baakman_2021_Br.J.Clin.Pharmacol__ |
| PubMedID: 34964149 |
| Title : No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model - Baakman_2019_Alzheimers.Dement.(N.Y)_5_89 |
| Author(s) : Baakman AC , Alvarez-Jimenez R , Loewen G , de Kam ML , Broekhuizen K , Hilt DC , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 5 :89 , 2019 |
| Abstract : Baakman_2019_Alzheimers.Dement.(N.Y)_5_89 |
| ESTHER : Baakman_2019_Alzheimers.Dement.(N.Y)_5_89 |
| PubMedSearch : Baakman_2019_Alzheimers.Dement.(N.Y)_5_89 |
| PubMedID: 30984817 |
| Title : First in human study with a prodrug of galantamine: Improved benefit-risk ratio? - Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| Author(s) : Baakman AC , t Hart E , Kay DG , Stevens J , Klaassen ES , Maelicke A , Groeneveld GJ |
| Ref : Alzheimers Dement (N Y) , 2 :13 , 2016 |
| Abstract : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| ESTHER : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| PubMedSearch : Baakman_2016_Alzheimers.Dement.(N.Y)_2_13 |
| PubMedID: 29067291 |